Stefan Herr - Profile and Investment Details

Investor Profile

Stefan Herr is a Micro VC, Venture Capital, Private Equity Firm based in Hesse, Germany with a diverse investment portfolio that includes companies such as Topas Therapeutics, Crescendo Biologics, ImevaX, Endoart, Vasopharm, Arsanis, immatics biotechnologies, Affectis Pharmaceuticals, Luxendo, Vira Therapeutics, ELARA Pharmaceuticals, Opsona, Allecra Therapeutics. Over time, Stefan Herr has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Stefan Herr is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Chemical Engineering, Chemical, Life Science, Biotech, Bioinformatics, Manufacturing, Healthcare, Biotechnology, Medical, Therapeutics, Advanced Materials, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Stefan Herr, as their portfolio suggests a familiarity and interest in this area.

Understanding Stefan Herr’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.